Rutten GEHM
England
Research Article
Leader 8: Type 2 Diabetes Patients: A Comparison of Baseline Characteristics of Eastern and Western European Participants with Established Cardiovascular Disease in the LEADER Trial
Author(s): Franek E, Rutten GEHM, Orsted DD, Baeres FMM, Mota M, Jacob S, Bain SC, Vidal J and Haluzik MFranek E, Rutten GEHM, Orsted DD, Baeres FMM, Mota M, Jacob S, Bain SC, Vidal J and Haluzik M
Aim: The aim of the present analysis was to compare cardiovascular disease risk factors in patients from
different countries in Europe, using baseline data from the Liraglutide Effect and Action in Diabetes: Evaluation of
cardiovascular outcome Results (LEADER) trial.
Methods: Baseline characteristics and treatments were compared between the subgroup of patients with
established cardiovascular disease included in this study from the Eastern European Union (EEU), Western
European Union (WEU), and Russia and Serbia (Ru/Se).
Results: Glycaemic control was similar in the EEU and WEU, and poorest in Ru/Se, although WEU patients
were older and had longer diabetes duration. Systolic blood pressure was lowest in Ru/Se, whereas diastolic blood
pressure was lowest in the W.. View More»
